Tesamorelin (Egrifta, and the later reformulations Egrifta SV and Egrifta WR) is indicated to reduce excess visceral (abdominal) adipose tissue in patients with HIV-associated lipodystrophy a condition in which antiretroviral therapy and HIV itself drive an abnormal accumulation of deep abdominal fat
The observation that cholinesterase inhibitors could improve apathy symptoms in AD patients further suggests that the basal forebrain, the major structure hosting central cholinergic neurons, may be involved in apathy in AD
It is also not for use in individuals with a history of pancreatitis or those with type 1 diabetes
The applicant must respond within 60 days with detailed patent-by-patent positions: for each patent on the RPS list, the applicant must state whether it agrees to a license or provide a detailed claim chart explaining its invalidity and non-infringement arguments
John had had a lot of difficulty in getting anybody interested in it at all, recalls Andrew Young, the former VP of research at Amylin Pharmaceuticals
